Prediabetes as opportunity and duty of treatment in people with obesity

Marcela Rodríguez-Flores, Obesity Department, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico
Roopa Mehta, Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
Ricardo Reynoso-Mendoza, Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico
Carlos A. Aguilar-Salinas, Metabolic Diseases Research Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

of lifestyle and some drugs can delay the incidence of diabetes in this population, or even revert the clinical and biochemical markers of prediabetes, has generated significant importance and research for targeting prediabetes as an opportunity to reduce the impact of diabetes in populations. In conclusion, prediabetes is a condition that increases the risk to develop type 2 diabetes and cardiovascular disease. Overweight and obesity promote its pathophysiology, and therefore, systematic detection practices could be beneficial in certain populations, given that interventions to improve the quality of nutrition and physical activity and the use of drugs such as metformin have proven to reduce the incidence of cardiovascular diseases and certain types of cancer in individuals with this condition.